Share this article
Share this article
NEW YORK, Aug. 3, 2021 /PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against Home Point Capital Inc. ( Home Point or the Company )(NASDAQ: HMPT) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of Michigan, and docketed under 21-cv-11457, is on behalf of all persons and entities other than Defendants that purchased or otherwise acquired Home Point common stock pursuant and/or traceable to the Company s January 29, 2021, initial public offering (the IPO or Offering ), seeking to recover compensable damages caused by Defendants violations of the federal securities laws and to pursue remedies under Sections 11 and 15 of the Securities Act of 1933 (the Securities Act ) (the Class ). The claims in this action arise from Home Point s materially misleading Offering Documents (defined below) issued in connection with the IPO.
Share this article
Share this article
NEW YORK, Aug. 3, 2021 /PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against Ocugen, Inc. ( Ocugen or the Company ) (NASDAQ: OCGN) and certain of its officers. The class action, filed in the United States District Court for the Eastern District of Pennsylvania, and docketed under 21-cv-03182, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Ocugen securities between February 2, 2021, and June 10, 2021, inclusive (the Class Period ), seeking to recover damages for violations of the federal securities laws under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act ), and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Share this article
Share this article
NEW YORK, Aug. 3, 2021 /PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against 360 DigiTech, Inc. ( 360 DigiTech , or the Company ) (NASDAQ: QFIN) and certain of its officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 21-cv-06013, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired 360 DigiTech securities between April 30, 2020 and July 7, 2021, both dates inclusive (the Class Period ), seeking to recover damages caused by Defendants violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act ) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
Business Notes
By Staff | Aug 3, 2021
PHOTO PROVIDED
Chamber President and Chief Executive Officer John Lai and Col. Andrew Kelly with Callie Johnson, Mark Blust and Chris Davidson, members of the chamber s Government Affairs Committee.
CHAMBER TO HOST BUSINESS LUNCHEON
The Sanibel & Captiva Islands Chamber of Commerce will hold its next business luncheon meeting on Aug. 11 starting at noon at the Pink Shell Beach Resort, at 275 Estero Blvd., Fort Myers Beach.
The guest speaker is Col. Andrew Kelly, commander and district engineer of the Jacksonville District of the U.S. Army Corps of Engineers.
The meeting is being held in partnership with the Florida Restaurant & Lodging Association and is sponsored by Captains for Clean Water and Rapid Response Team.
Share this article
Share this article
NEW YORK, Aug. 3, 2021 /PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against AcelRx Pharmaceuticals, Inc. ( AcelRx or the Company ) (NASDAQ: ACRX) and certain of its officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 21-cv-04353, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired AcelRx securities between March 17, 2020 and February 12, 2021, both dates inclusive (the Class Period ), seeking to recover damages caused by Defendants violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act ) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.